These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24371328)

  • 1. Targeting the hypoxia-sensing pathway in clinical hematology.
    Forristal CE; Levesque JP
    Stem Cells Transl Med; 2014 Feb; 3(2):135-40. PubMed ID: 24371328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic stabilization of HIF-1α increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation.
    Forristal CE; Winkler IG; Nowlan B; Barbier V; Walkinshaw G; Levesque JP
    Blood; 2013 Jan; 121(5):759-69. PubMed ID: 23243286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viability.
    Krock BL; Eisinger-Mathason TS; Giannoukos DN; Shay JE; Gohil M; Lee DS; Nakazawa MS; Sesen J; Skuli N; Simon MC
    Blood; 2015 May; 125(21):3263-72. PubMed ID: 25855602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
    Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
    J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the HIFs, buts and maybes of hypoxia signalling in disease: lessons from zebrafish models.
    Elks PM; Renshaw SA; Meijer AH; Walmsley SR; van Eeden FJ
    Dis Model Mech; 2015 Nov; 8(11):1349-60. PubMed ID: 26512123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets.
    Kling L; Schreiber A; Eckardt KU; Kettritz R
    J Leukoc Biol; 2021 Jul; 110(1):61-75. PubMed ID: 33070368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.
    Prabhakar NR; Semenza GL
    Physiol Rev; 2012 Jul; 92(3):967-1003. PubMed ID: 22811423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and regulation of prolyl hydroxylase domain proteins.
    Fong GH; Takeda K
    Cell Death Differ; 2008 Apr; 15(4):635-41. PubMed ID: 18259202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H; Sridharan V; Wright G
    Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
    Floyd ZE; Kilroy G; Wu X; Gimble JM
    J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells.
    Katagiri N; Hitomi H; Mae SI; Kotaka M; Lei L; Yamamoto T; Nishiyama A; Osafune K
    Sci Rep; 2021 Feb; 11(1):3936. PubMed ID: 33594180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF Activation Against CVD in CKD: Novel Treatment Opportunities.
    Tanaka T; Eckardt KU
    Semin Nephrol; 2018 May; 38(3):267-276. PubMed ID: 29753402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.
    Forristal CE; Nowlan B; Jacobsen RN; Barbier V; Walkinshaw G; Walkley CR; Winkler IG; Levesque JP
    Leukemia; 2015 Jun; 29(6):1366-78. PubMed ID: 25578474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes.
    Copple BL; Bustamante JJ; Welch TP; Kim ND; Moon JO
    Liver Int; 2009 Aug; 29(7):1010-21. PubMed ID: 19302442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.
    Bao X; Zhang J; Huang G; Yan J; Xu C; Dou Z; Sun C; Zhang H
    Cell Death Dis; 2021 Feb; 12(2):215. PubMed ID: 33637686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
    Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
    Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged fasting activates hypoxia inducible factors-1α, -2α and -3α in a tissue-specific manner in northern elephant seal pups.
    Soñanez-Organis JG; Vázquez-Medina JP; Crocker DE; Ortiz RM
    Gene; 2013 Sep; 526(2):155-63. PubMed ID: 23707926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis.
    Wielockx B; Grinenko T; Mirtschink P; Chavakis T
    Cells; 2019 Feb; 8(2):. PubMed ID: 30781787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α activation results in actin cytoskeleton reorganization and modulation of Rac-1 signaling in endothelial cells.
    Weidemann A; Breyer J; Rehm M; Eckardt KU; Daniel C; Cicha I; Giehl K; Goppelt-Struebe M
    Cell Commun Signal; 2013 Oct; 11():80. PubMed ID: 24144209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.